Pfizer, BioNTech report high efficacy of COVID-19 booster shot in study
Published
Pfizer Inc and German partner BioNTech SE on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of...
Full ArticlePublished
Pfizer Inc and German partner BioNTech SE on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of...
Full ArticleU.S. pharmaceutical company Pfizer and its German partner, BioNTech, Friday released data from studies showing their COVID-19..
A booster dose of the COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech SE restored efficacy to 95.6% against..